Skip to search formSkip to main contentSkip to account menu

florbetapir

Known as: 2-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)-5-(4-methylaminostyryl)pyridine, 4-(2-(6-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)pyridin-3-yl)vinyl)-N-methylbenzamide 
National Institutes of Health

Related topics

Related topics

5 relations

Narrower (3)

18F-AV-45AmyvidFLORBETAPIR F-18

Broader (2)

Aniline CompoundsEthylene Glycols

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Florbetapir Image Analysis for Alzheimer's Disease Diagnosis
Over decades Alzheimer's disease (AD) remains without decent cure, and only disease-modifying methods are available. This paper… 
Review
2016
Review
2016
[Clinical Implications and Appropriate Use of Amyloid Imaging with florbetapir (18F) in Diagnosis of Patients with Alzheimer Disease].
florbetapir (18F) is a radiolabeled compound that can be used to visualize amyloid-beta (Aβ) plaques in the brains of patients… 
2015
2015
Restricting access to florbetapir: Medicare coverage criteria for diagnostics and drugs are inconsistent
Medicare’s decision to restrict coverage of florbetapir, a diagnostic agent for Alzheimer’s disease, exemplifies an inconsistent… 
2015
2015
Common Variants in PLD3 and Correlation to Amyloid-Related Phenotypes in Alzheimer's Disease.
The phospholipase D3 (PLD3) gene has shown association with Alzheimer's disease (AD). However, the role of PLD3 common variants… 
2015
2015
Clinical Amyloid Imaging in Logopenic Progressive Aphasia
The introduction of florbetapir (Amyvid) positron emission tomography biomarkers could dramatically change how we clinically… 
2014
2014
Molecular imaging of misfolded protein pathology for early clues to involvement of the heart
2014
2014
A consecutive case series experience with [18 F] florbetapir PET imaging in an urban dementia center: impact on quality of life, decision making, and disposition
Identification and quantification of fibrillar amyloid in brain using positron emission tomography (PET) imaging and Amyvid™ ([18… 
2013
2013
Florbetapir F 18 for brain imaging of β-amyloid plaques.
Recent trends in neurodegeneration research have been aimed at developing new amyloid ligands for the neuroimaging of dementia… 
Review
2012
Review
2012
First FDA-approved beta-amyloid diagnostic hits the market
“This allows us to focus on the important question of whether there are real barriers to drug innovation in the US. But it’s… 
2012
2012
Alzheimer disease: Florbetapir—a useful tool to image amyloid load and predict cognitive decline in Alzheimer disease
Alzheimer disease: Florbetapir—a useful tool to image amyloid load and predict cognitive decline in Alzheimer disease 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)